ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,297.10
-0.21%
Dow Jones
39,869.38
-0.10%
US Dollar vs MXN
16.6927
0.07%
Brent Oil
83.235
0.04%
Bitcoin
65,206.83
-0.05%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Nevro Corp (NVRO)

  7. Nevro Corp (NVRO) Noticias

NVRO

Nevro (NVRO)

Nevro Corp
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:NVRO
FechaHoraFuenteTítuloSímboloCompañía
09/05/202415:52Edgar (US Regulatory)Form 8-K - Current reportNYSE:NVRONevro Corp
09/05/202415:05PR Newswire (US)Nevro to Present at BofA Securities 2024 Healthcare ConferenceNYSE:NVRONevro Corp
07/05/202415:56Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:NVRONevro Corp
07/05/202415:05PR Newswire (US)Nevro Reports First-Quarter 2024 Financial ResultsNYSE:NVRONevro Corp
17/04/202407:30PR Newswire (US)Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024NYSE:NVRONevro Corp
11/03/202415:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
28/02/202415:10PR Newswire (US)Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral ScrewNYSE:NVRONevro Corp
23/02/202416:08Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:NVRONevro Corp
22/02/202415:16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:NVRONevro Corp
21/02/202415:06PR Newswire (US)Nevro Enters Into Cooperation Agreement With Engaged CapitalNYSE:NVRONevro Corp
21/02/202415:05PR Newswire (US)Nevro Reports Fourth-Quarter and Full-Year 2023 Financial ResultsNYSE:NVRONevro Corp
14/02/202414:47Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNYSE:NVRONevro Corp
01/02/202415:30PR Newswire (US)Nevro Announces Consensus Statement Supporting High-Frequency (10 kHz) Spinal Cord Stimulation Therapy for Refractory Painful Diabetic NeuropathyNYSE:NVRONevro Corp
29/01/202415:30PR Newswire (US)Nevro to Report Fourth-Quarter and Full-Year 2023 Financial Results and Host Conference Call on February 21, 2024NYSE:NVRONevro Corp
18/01/202415:15PR Newswire (US)Nevro Announces Positive Coverage Update from Carelon Healthcare for the Treatment of Painful Diabetic NeuropathyNYSE:NVRONevro Corp
17/01/202415:15PR Newswire (US)Nevro to Highlight 25 Scientific Abstracts at 2024 North American Neuromodulation Society (NANS) Annual MeetingNYSE:NVRONevro Corp
10/01/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNYSE:NVRONevro Corp
10/01/202416:26Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NYSE:NVRONevro Corp
09/01/202407:30PR Newswire (US)Nevro Announces Preliminary Fourth-Quarter and Full-Year 2023 Revenue ResultsNYSE:NVRONevro Corp
04/01/202415:15PR Newswire (US)Nevro to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNYSE:NVRONevro Corp
11/12/202308:00Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNYSE:NVRONevro Corp
30/11/202316:19PR Newswire (US)Nevro Announces Acquisition of Vyrsa™ TechnologiesNYSE:NVRONevro Corp
20/11/202306:00PR Newswire (US)Nevro Delivers Long-Term Relief with High-Frequency Spinal Cord Stimulation: 24-Month Data Demonstrates Profound Improvements for Non-Surgical Refractory Back PainNYSE:NVRONevro Corp
01/11/202315:01PR Newswire (US)Nevro Reports Third Quarter 2023 Financial Results, Provides Fourth Quarter Guidance and Updates Full-Year 2023 GuidanceNYSE:NVRONevro Corp
04/10/202306:00PR Newswire (US)Nevro to Report Third Quarter 2023 Financial ResultsNYSE:NVRONevro Corp
18/09/202306:00PR Newswire (US)New Data Demonstrate the Health Economic Benefits of Nevro's High-Frequency Spinal Cord Stimulation TherapyNYSE:NVRONevro Corp
23/08/202306:00PR Newswire (US)Nevro Announces Participation in Upcoming Investor ConferencesNYSE:NVRONevro Corp
16/08/202306:00PR Newswire (US)New 24-Month Data Shows Nevro's SCS Therapy Provides Highly Effective, Long-Term Relief from Painful Diabetic NeuropathyNYSE:NVRONevro Corp
10/08/202303:52PR Newswire (US)Nevro announces launch of HFX Connect™ in Europe and CE marking of expanded labelling for the HFX™ SCS system.NYSE:NVRONevro Corp
01/08/202315:03PR Newswire (US)Nevro Reports Second Quarter 2023 Financial Results, Provides Third Quarter Guidance and Updates Full-Year 2023 GuidanceNYSE:NVRONevro Corp
 Showing the most relevant articles for your search:NYSE:NVRO

Su Consulta Reciente

CCOM
US30
US 30
FX
EURMXN
Euro vs MXN
NYSE
KO
Coca Cola
USOTC
BASFY
BASF (QX)
NASDAQ
MSFT
Microsoft
USI
USTECH100
US Tech 100
NASDAQ
TSLA
Tesla
NYSE
JPM
JP Morgan Chase
COIN
BTCUSD
Bitcoin
CCOM
SILVER
SILVER
USOTC
RHHBY
Roche (QX)
USOTC
ADDYY
Adidas (QX)
NYSE
MCD
McDonalds
COIN
SOLUSD
Solana
NYSE
AXP
American Express
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados